These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1689967)

  • 21. Flow cytometric analysis of hydroxyurea effects on fetal hemoglobin production in cultures of beta-thalassemia erythroid precursors.
    Amoyal I; Goldfarb A; Fibach E
    Hemoglobin; 2003 May; 27(2):77-87. PubMed ID: 12779269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological induction of foetal haemoglobin synthesis in sickle-cell disease.
    Saleh AW; Hillen HF
    Neth J Med; 1997 Nov; 51(5):169-78. PubMed ID: 9455096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
    Yang YM; Pace B
    Pediatr Pathol Mol Med; 2001; 20(1):87-106. PubMed ID: 12673846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulation of fetal hemoglobin production by hydroxyurea in sickle cell anemia.
    Dover GJ; Charache S
    Prog Clin Biol Res; 1989; 316B():295-306. PubMed ID: 2482499
    [No Abstract]   [Full Text] [Related]  

  • 25. On the induction of fetal hemoglobin in the adult; stress erythropoiesis, cell cycle-specific drugs, and recombinant erythropoietin.
    Stamatoyannopoulos G; Veith R; Al-Khatti A; Fritsch EF; Goldwasser E; Papayannopoulou T
    Prog Clin Biol Res; 1987; 251():443-53. PubMed ID: 2448812
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of recombinant human erythropoietin on the switchover from fetal to adult hemoglobin synthesis in preterm infants.
    Bard H; Widness JA
    J Pediatr; 1995 Sep; 127(3):478-80. PubMed ID: 7544827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zileuton induces hemoglobin F synthesis in erythroid progenitors: role of the L-arginine-nitric oxide signaling pathway.
    Haynes J; Baliga BS; Obiako B; Ofori-Acquah S; Pace B
    Blood; 2004 May; 103(10):3945-50. PubMed ID: 14764535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxyurea and erythropoietin therapy in sickle cell anemia.
    Goldberg MA; Brugnara C; Dover GJ; Schapira L; Lacroix L; Bunn HF
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):74-81. PubMed ID: 1379376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fetal hemoglobin and erythropoietin.
    N Engl J Med; 1988 Feb; 318(7):449-51. PubMed ID: 2448624
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA
    Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
    [No Abstract]   [Full Text] [Related]  

  • 31. Fetal hemoglobin reactivation in baboon and man: a short perspective.
    Lavelle D; DeSimone J; Heller P
    Am J Hematol; 1993 Jan; 42(1):91-5. PubMed ID: 7677951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fetal and maternal progenitor cells in co-culture respond equally to erythropoietin.
    Bohmer RM; Johnson KL; Bianchi DW
    Prenat Diagn; 2001 Oct; 21(10):818-23. PubMed ID: 11746121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing fetal hemoglobin production in sickle cell disease: results of clinical trials.
    Dover GJ; Charache S
    Prog Clin Biol Res; 1987; 251():455-66. PubMed ID: 2448813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxyurea therapy in thalassemia.
    Loukopoulos D; Voskaridou E; Stamoulakatou A; Papassotiriou Y; Kalotychou V; Loutradi A; Cozma G; Tsiarta H; Pavlides N
    Ann N Y Acad Sci; 1998 Jun; 850():120-8. PubMed ID: 9668534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
    Pecoraro A; Troia A; Calzolari R; Scazzone C; Rigano P; Martorana A; Sacco M; Maggio A; Di Marzo R
    Hemoglobin; 2015; 39(4):225-9. PubMed ID: 26016899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined effects of arginine and hydroxyurea on BFU-E derived colony growth and HbF synthesis in erythroid progenitors isolated from sickle cell blood.
    Baliga BS; Haynes J; Obiako B; Mishra N
    Cell Mol Biol (Noisy-le-grand); 2010 Jun; 56 Suppl():OL1290-8. PubMed ID: 20937216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemoglobin switching in humans is accompanied by changes in the ratio of the transcription factors, GATA-1 and SP1.
    Bacon ER; Dalyot N; Filon D; Schreiber L; Rachmilewitz EA; Oppenheim A
    Mol Med; 1995 Mar; 1(3):297-305. PubMed ID: 8529108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapies to increase fetal hemoglobin in sickle cell disease.
    Steinberg MH
    Curr Hematol Rep; 2003 Mar; 2(2):95-101. PubMed ID: 12901139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
    Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
    Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemotherapy and hemoglobin F synthesis in sickle cell disease.
    Dover GJ; Charache S
    Ann N Y Acad Sci; 1989; 565():222-7. PubMed ID: 2476061
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.